Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Biostar Pharma To Effect Reverse Stock Split - Quick Facts

Biostar Pharmaceuticals Inc. (BSPM) announced that its Board unanimously approved a reverse split of its common stock at a ratio of 1-for-3, with anticipated trading on the post-split basis on NASDAQ commencing at the open of the stock market on April 4, 2012.

Accordingly, as of the effective date of the reverse split, each 3 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock. In addition, the common stock will trade under a new CUSIP number.

The company's ticker symbol will remain unchanged. As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 9,398,892, the company said.

Click here to receive FREE breaking news email alerts for Biostar Pharmaceuticals Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With energy prices showing a significant increase amid rising gasoline prices, the Labor Department released a report on Tuesday showing that U.S. consumer prices rose in line with economist estimates in the month of June. Stocks are likely to move back to the upside in early trading on Tuesday after ending the previous session modestly lower. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 55 points. Use of traditional telephony services in the European Union is decreasing as Internet (VoIP) services have become increasingly popular, according to a report on state of EU Telecommunications markets. Tuesday, the European Commission published the 2012 - 2013 report on the telecommunications market and regulation in the EU. The majority of European countries have established broadband plans with
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.